Bile Duct Cancer Drug Market Size, Share, Growth Report 2030

Bile Duct Cancer Drug Market

Bile Duct Cancer Drug Market by Type (5-fluorouracil (5-FU), Gemcitabine, Cisplatin, Capecitabine, Oxaliplatin, and Others) and by Application (Hospitals, Clinics, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024

Published Date: 07-Jan-2019 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-3702 Status : Published

Global bile duct cancer drug market expected to generate revenue of around USD 262 million by 2024, at a CAGR of around 6.6% between 2018 and 2024. The major growth driver of the global bile duct cancer drug market is the increase in the prevalence of bile duct cancer patients across the globe.

The report covers a forecast and an analysis of the bile duct cancer drug market on a global and regional level. The study provides historical data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD million). The study includes drivers and restraints for the bile duct cancer drug market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the bile duct cancer drug market on a global level.

In order to give the users of this report a comprehensive view of the bile duct cancer drug market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Bile Duct Cancer Drug MarketRequest Free Sample

The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis. 

The study provides a decisive view on the bile duct cancer drug market by segmenting the market based on type, application, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024.

By type, bile duct cancer drug market is segmented as 5-fluorouracil (5-FU), capecitabine, gemcitabine, oxaliplatin, cisplatin, and other. Based on application, bile duct cancer drug market has been segmented into hospitals, clinics, and others. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S., Germany, Italy, France, UK, China, Japan, India, and Brazil.

Some key players of the bile duct cancer drug market include Delcath Systems Inc., Accord Healthcare, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, Pfizer Inc., Eli Lilly and Company, Mylan N.V, Fresenius Kabi AG, Intercept Pharmaceuticals, Inc., and Celgene Corporation, among others.

This report segments the global bile duct cancer drug market into:

Global Bile Duct Cancer Drug Market: By Product

  • 5-fluorouracil (5-FU)
  • Gemcitabine
  • Cisplatin
  • Capecitabine
  • Oxaliplatin
  • Others

Global Bile Duct Cancer Drug Market: By Application

  • Hospitals
  • Clinics
  • Others

Global Bile Duct Cancer Drug Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

Methodology

Free Analysis

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed